Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-013484

Chief Scientific Officer sold 17,446 shares at an average $41.48 ($723,625)

From the SEC's structured data for this filing

Trades in this filing

Leen Ann M. · Chief Scientific Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-19 Sale : show line 1 in the form −7,541 $41.75 $314,868 2,481,590 I
2021-02-22 Sale : show line 2 in the form −1,200 $41.54 $49,846 2,480,390 I
2021-02-22 Sale : show line 3 in the form −4,506 $42.84 $193,034 2,475,884 I
2021-02-23 Sale : show line 4 in the form −1,492 $38.83 $57,931 2,474,392 I
2021-02-23 Sale : show line 5 in the form −1,907 $39.59 $75,498 2,472,485 I
2021-02-23 Sale : show line 6 in the form −800 $40.56 $32,448 2,471,685 I
Open-market sales · 17,446 sh · avg $41.48 · $723,625
Loading xslF345X03/doc4.xml…